Tag | Content |
---|
EnhancerAtlas ID | HS139-16514 |
Organism | Homo sapiens |
Tissue/cell | Myotube |
Coordinate | chr14:54080470-54082520 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
MEF2C | MA0497.1 | chr14:54081439-54081454 | TTTTTAAAAATAGCA | + | 6.19 | RFX1 | MA0509.2 | chr14:54081478-54081494 | TGTTATTATGATAACG | + | 6.17 | RFX1 | MA0509.2 | chr14:54081478-54081494 | TGTTATTATGATAACG | - | 6.17 | SCRT1 | MA0743.1 | chr14:54080790-54080805 | GGCCACCTGTTGATC | - | 6.84 | SCRT2 | MA0744.1 | chr14:54080792-54080805 | CCACCTGTTGATC | - | 6.34 |
|
| Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
SE_59592 | chr14:54073813-54089532 | Ly3 | SE_61354 | chr14:54070168-54089397 | HBL1 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH14I053612 | chr14 | 54079437 | 54082262 |
|
Enhancer Sequence | CAACCTTTGA TTCAGATGTT TTCACTTCCT CCTCTTCTTA CGTATGGCCC TTTGGTCTCT 60 GTCCCCTAGG CTGACTTTCA TCATCCAATT AGAAATAACA CCGTCTTCTT GCTACCATTT 120 CTCTGGGAAC CGTAGGGAGT AGACCCCCAG CCTCCTGCAC TCCCCACAGG GGCCAGCCGA 180 GCTTCAAAGG AGTGTGTTGG CAGCACCACC TCACGGCTGG GCTTCCTTTC TGTTTGAACA 240 GCTTCCATTG CTCACTGTTG ATCAGTAACT CAATGATTCA TTAAACACAC AAACAATGAG 300 TGAATCTGTT CCATTAGCAA GGCCACCTGT TGATCTCAGA CATTCTTAGC TGAACTCGGC 360 AAATACGAAC AACAGAATGC CTACATCAGT CGAGTGCTCT GTCTCTATTT GATGGCATGT 420 TAGAGCAGGA AAAGCAGAGT CCAGGCTTTG CTGATGCTTT TATGCTTTTC CTTTCATCTG 480 GTGGCAGGGC TGTAAGAGTA AAATGTGGAA CACAACCCAC CTCTCTATAA GCAGCTGGAA 540 AACTTTAAGA GCTTGGTCGC TGTTCCTTCC TCAGTCTTGT AGAATTAGAG AAAAAGGAGA 600 GTGGGAATAT TCTGTACCCT TTTGCTTGCA GGTGCAAGGG CAATAGAATT AACCAAGCCC 660 TAAACACACA CACACACACA CACACACACA CACACACACA CACACACACA CACACACACC 720 AAAAGAAGAA AAACTGTAAA AGACATCTTA TTGATTGCAA TGACACCTTC TCTGCCTTAG 780 AAAAAATACA ATCTCTTTTC TATGTAGCTT CTGGTTCATG TAGCTGTTCC AGGCCTTTAA 840 GAACTGGTCT ACTAGTGTTT ACAAGCTTTT AAAAAATATT ATACTTTATT TGGCTACTAA 900 AAGTCATATA AAGCAGACTG GGTTAAGCTG TTGATACAGG CATCACGGTC AATAAAAGTT 960 GAAATTTTAT TTTTAAAAAT AGCATTTTTC CTCTCTTATA ATTCCTCTTG TTATTATGAT 1020 AACGAGGAGA GCTTTTATAA AGTGGGTGGT ATTTGTTTGA AACCTGAAAG GTGTACCATA 1080 CCAGGAATAA AGAGACACTT GTTCTTTTCT CAGTTAAATA CTAAATTGCC TCTTTAGGGT 1140 GAATTTAGTA TTTAAATGCA TAATTATTAT GATTTGTACT GTGTTAAGTT TAAATTTCTC 1200 TGCAGTGACA CTGATTAAAC ACAGCTCAGT GTTTCTGTTT GATAGATTTA TTCTAGGATA 1260 TCAGTAAAAA CTTGGTTGGT TGGTTGGTTG GTTGGTTCTT GTAATCAAAT GGAAGATGAA 1320 GAAGCAGAAG GAAACAACTC TTCAAATAAA ATTCCAGTTC CTATGAATTT ATTATGTAAA 1380 ATATATAAAA TCATGAGTTT TAAATTTCCC ACTGGATTTC GGAAATGACT GTTGCTAGTG 1440 GCTGGTTTAC TTTCATTTGT GTGGCACTGG AAATGACAGA GTGCCAGGTG AGGAATTCAG 1500 TTTGTGTCTC TTTTGTAAAT ATTCTTTTGC TTTGGGAGGA CATGCTTTGA GCTACACACA 1560 TTCAGAATGA ATAAGGTGAA CAGATTGAGG CAGGCAGACC CCACTACTTG GATTCTCTAG 1620 GCAGGTGTGA GCATATCTCG CTCATCCAAT ACATAAAAGA CCACGTGCAT TTTCAAAGGG 1680 ATTTCTGCAA TCCCTTTTGC AATCTTTTGA CAACCACTAC TATGATCTGA TTGCCCAATG 1740 CAGGTGCTTG TGCAGCCGCC CCACTGTGCC ATCAAAAGAA TCCTCAGATT CTTCTGACTA 1800 AAAGGGACAG GCAGAAGAAG TAACTTTTTA AAAAGACTAA AAAGGAAATA GCCACATAAA 1860 ATGAAAAATT AGATGGAAGG TGAATAGCTA TCCCCTCCTG TGATTAGATT GTCACCATCC 1920 AATAGAACTT TCTGCAGTGA TACAAATGTT CGATACCTGC ACTAACCAGT GTGAGAGCCA 1980 CTAGCCACAT GTGACTACTG AGCATTTGAA ATGTGGCTAG TGTGACTGGG AAATTAAAAT 2040 TTAATTTTAA 2050
|